Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Statistical Applications in Genetics and Molecular Biology|April 14, 2012
A generalized hidden Markov model for determining sequence-based predictors of nucleosome positioningCarlee Moser, Mayetri Gupta
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2019
Immune Biomarkers in the Prediction of Future Myocardial Infarctions in People With Human Immunodeficiency VirusJanine M Trevillyan, Carlee Moser, Judith S Currier, et al.
AIDS (London, England)|June 4, 2019
Soluble suppression of tumorigenicity 2 levels are not predictive of non-AIDS events during antiretroviral therapy-mediated viral suppressionAlexis Kay, Carlee Moser, Ashley McKhann, et al.
Antiviral Therapy|March 2, 2017
Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changesPriya Bhagwat, Ighovwerha Ofotokun, Grace A McComsey, et al.
Open Forum Infectious Diseases|November 23, 2018
Changes in Waist Circumference in HIV-Infected Individuals Initiating a Raltegravir or Protease Inhibitor Regimen: Effects of Sex and RacePriya Bhagwat, Ighovwerha Ofotokun, Grace A McComsey, et al.
AIDS Research and Human Retroviruses|July 7, 2020
Short Communication: Impact of Fat Changes on the Effect of Protease Inhibitors on Lumbar Spine Bone Mineral Density Changes with Antiretroviral Therapy InitiationJoshua Garza, Carlee Moser, Douglas W Kitch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2021
Adipokines, Weight Gain and Metabolic and Inflammatory Markers After Antiretroviral Therapy Initiation: AIDS Clinical Trials Group (ACTG) A5260sJohn R Koethe, Carlee Moser, Todd T Brown, et al.
Open Forum Infectious Diseases|October 6, 2016
Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260sSahera Dirajlal-Fargo, Carlee Moser, Todd T Brown, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2019
CT Fat Density Accurately Reflects Histologic Fat Quality in Adults With HIV On and Off Antiretroviral TherapyJordan E Lake, Carlee Moser, Liz Johnston, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2018
Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral TherapyVanessa El Kamari, Carlee Moser, Corrilynn O Hileman, et al.
Pageof 7